Abstract
A pro-thrombotic condition was described in 1983 which was characterised by the presence of circulating antiphospholipid antibodies, as well as peripheral thrombosis (e.g. DVT), a tendency to internal organ involvement, repeated miscarriage, and, occasionally, thrombocytopenia (aPL) (Hughes, Br Med J 287:1088–1089, 1983). Previously, there had been a number of observations, mainly in patients with lupus having “false positive” tests for syphilis, miscarriage and circulating lupus anticoagulants. The description in 1983 had three notable features (a) a detailed comprehensive clinical picture of the syndrome; (b) this description differed from other coagulopathies in showing a propensity for arterial thrombosis (e.g. stroke and heart attack); and (c) this was a syndrome quite independent from lupus. There are indications that the primary antiphospholipid syndrome will turn out to be more common than lupus, though this could still be a reflection of referral practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adamson R, Sangle S, Kaul A, Hughes GRV, D’Cruz DP (2008) Clinical improvement in antiphospholipid syndrome after rituximab therapy. J Clin Rheumatol 14:359–360
Blank M, Zandman-Goddard G, Krause I et al (2007) The efficacy of specific IVIG antiidiotypical antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol 7:857–865
Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunological mechanisms and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46(101):9–27
Cimaz R, Meroni L, Shoenfeld Y (2006) Epilepsy as part of systemic lupus erythematousus and systemic antiphospholipid syndrome (Hughes Syndrome). Lupus 15:191–194
Cuadrado MJ, Khamashta MA, Hughes GRV (2001) Sticky blood and headache. Lupus 10:392–393
Cuadrado MJ, Khamashta MA, Ballesteros A et al (2002) Can Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Medicine (Baltimore) 79:57–68
Cuadrado MJ, Wakefield K, Sanna G, Khamashta MA, Hughes GRV (2004) Multiple sclerosis in the antiphospholipid (Hughes) syndrome. A common differential diagnosis? Clin Exp Rheumatol 22:652–653
Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039
George J, Shoenfeld Y (1987) The antiphospholipid (Hughes) syndrome: a cross-roads of autoimmunity and atherosclerosis. Lupus 6:559–560
Greco T, Conti-Kelly AH, Greco T Jr et al (2009) Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome. Coagul Transfus Med 132:613–620
Harris EN, Gharavi, AE Boey ML, Patel BM, Mackworth-Young CG. Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmuno-assay and association with thrombosis in SLE. Lancet 2:1211–1214
Hughes GRV (1983) Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 287:1088–1089
Hughes GRV (1988) Hughes Syndrome: the antiphospholipid syndrome—a historical view. Lupus 7:S1–S4
Hughes GRV (2003) Migraine, memory loss and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes) syndrome. Postgrad Med J 79:81–3
Hughes GRV (2010a) Antiphospholipid syndrome, migraine and stroke. Lupus 19:555–556
Hughes GRV (2010b) Hughes Syndrome (antiphospholipid syndrome) and myocardial infarction. Postgrad Med J 79:81–83
Hughes GRV (2010c) Hughes Syndrome (the antiphospholipid syndrome). Ten clinical lessons. Lupus 1988, 343–346. Int J Clin Pract 64:1183–1184
Hughes GRV, Khamashta MA (2003) Sero-negative antiphospholipid syndrome. Ann Rheum Dis 62:1127
Letellier E, Hughes GRV (2003) “Listen to the patient”—anticoagulation is critical in the antiphospholipid (Hughes) syndrome. J Rheumatol 30:897
Meroni PL, Peyvandi F, Foco L (2007) Anti-Beta 2 glycoprotein antibodies and the risk of myocardial infarction in young pre-menopausal women. J Thromb Haemost 5:2421–2428
Nair S, Khamashta MA, Hughes GRV (2002) Syndrome X and Hughes Syndrome. Lupus 11:332
Nencini P, Baruffi MC, Abbate R et al (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischaemia. Stroke 23:189–192
Sangle S, D’Cruz DP, Jan W (2003) Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 62:999–1002
Sangle S, D’Cruz D, Khamashta MA, Hughes GRV (2004) Antiphospholipid antibodies, SLE and non-traumatic metatarsal fractures. Ann Rheum Dis 63:1241–1243
Urbanus R, Siegerink B, Roest M et al (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the ratio study. Lancet (Neurology) 8(11):998–1005
Vaitla PM, McDermott EM (2010) The role of high-dose intravenous immunoglobulin in rheumatology. Rheumatology 49:1040–1048
Ziakis PD, Pavlou M, Vougarelis M (2010) Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. Obstet Gynaecol 115:1256–1262
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hughes, G.R.V. Hughes syndrome (the antiphospholipid syndrome): a disease of our time. Inflammopharmacol 19, 69–73 (2011). https://doi.org/10.1007/s10787-010-0071-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-010-0071-3